系统性硬化症患者差异表达基因与自身抗体类型的关联
结果显示不同自身抗体亚型富集出不同通路,巨噬细胞/单核细胞、内皮细胞和成纤维细胞与ACA、RNAP、ATA及皮肤病变严重程度相关。
要点
- 不同自身抗体亚型(ACA、RNP、RNAP、ATA)在SSc皮肤中富集出不同通路。
- 巨噬细胞/单核细胞、内皮细胞和成纤维细胞与ACA、RNAP、ATA及皮肤病变严重程度相关。
- 无特定自身抗体患者未显示独特富集通路,部分通路在各亚型间重叠。
核心结论
- 利用多中心队列患者和对照的基因表达数据,根据自身抗体类型识别了SSc的致病通路。
主要发现
- 与健康对照相比,无特定自身抗体、ACA、抗U1 RNP抗体(RNP)、抗RNA聚合酶III抗体(RNAP)和抗拓扑异构酶I抗体(ATA)患者分别获得2、71、10、144和78个差异表达基因。
- ACA独特富集通路为「角质形成细胞分化」,RNAP为「核因子κB信号」和「细胞对TGF-β刺激的反应」,RNP为「干扰素α/β信号」,ATA为「细胞对应激的反应」。
- 细胞类型特征评分分析显示巨噬细胞/单核细胞、内皮细胞和成纤维细胞与ACA、RNAP、ATA及SSc皮肤病变严重程度相关。
临床怎么用
- 不同自身抗体亚型对应不同皮肤基因表达通路,可能为SSc靶向治疗提供新方向。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aims of this study were to investigate the relationship between the type of autoantibody and gene expression profile in skin lesions from patients with SSc, and to identify specific dysregulated pathways in SSc patients compared with healthy controls. METHODS: Sixty-one patients with SSc from the Genetics vs Environment in Scleroderma Outcome Study cohort and 36 healthy controls were included in this study. Differentially expressed genes were extracted and functional enrichment and pathway analysis were conducted. RESULTS: Compared with healthy controls, lists containing 2, 71, 10, 144 and 78 differentially expressed genes were created for patients without specific autoantibody, ACA, anti-U1 RNP antibody (RNP), anti-RNA polymerase III antibody (RNAP) and anti-topoisomerase I antibody (ATA), respectively. While part of the enriched pathways overlapped, distinct pathways were identified except in those patients lacking specific autoantibody. The distinct enriched pathways included 'keratinocyte differentiation' for ACA, 'nuclear factor κB signalling' and 'cellular response to TGF-β stimulus' for RNAP, 'interferon α/β signalling' for RNP, and 'cellular response to stress' for ATA. Cell type signature score analysis revealed that macrophages/monocytes, endothelial cells and fibroblasts were associated with ACA, RNAP, ATA and the severity of the SSc skin lesions. CONCLUSION: Pathogenic pathways were identified according to the type of autoantibody by leveraging gene expression data of patients and controls from a multicentre cohort. The current study may promote the search for new therapeutic targets for SSc.
引用
- Inamo J. Association of differentially expressed genes and autoantibody type in patients with systemic sclerosis. Rheumatology (Oxford). 2021. PMID: 32911535. doi:10.1093/rheumatology/keaa447
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。